Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leon Sun

Showing results (31-40 of 96) with videos related to

Pageof 10
Sort By:
International Journal of Radiation Oncology, Biology, Physics|January 18, 2011
Impact of primary Gleason grade on risk stratification for Gleason score 7 prostate cancersBridget F Koontz, Matvey Tsivian, Vladimir Mouraviev, et al.
Cancer|July 1, 2010
Baseline PSA as a predictor of prostate cancer-specific mortality over the past 2 decades: Duke University experiencePing Tang, Leon Sun, Matthew A Uhlman, et al.
BJU International|November 6, 2010
Prostate-specific antigen velocity based risk-adapted discontinuation of prostate cancer screening in elderly menPing Tang, Leon Sun, Matthew A Uhlman, et al.
The Prostate|June 11, 2008
Pathologic stage T2a and T2b prostate cancer in the recent prostate-specific antigen era: implications for unilateral ablative therapyThomas J Polascik, Janice M Mayes, Leon Sun, et al.
Medical Oncology (Northwood, London, England)|December 25, 2012
Preoperative predictors of pathologic stage T2a and pathologic Gleason score ≤ 6 in men with clinical low-risk prostate cancer treated with radical prostatectomy: reference for active surveillanceQiang Fu, Judd W Moul, Lionel Bañez, et al.
Urologic Oncology|December 12, 2002
The role of radical prostatectomy in patients with pretreatment prostate-specific antigen > or = 40 ng/mLBill P Vanasupa, Edmond L Paquette, Hongyu Wu, et al.
Urology|November 14, 2002
Improved prostate cancer-specific survival and other disease parameters: impact of prostate-specific antigen testingEdmond L Paquette, Leon Sun, Laurence R Paquette, et al.
Cancer|May 29, 2007
Prostate cancer-specific mortality after radical prostatectomy or external beam radiation therapy in men with 1 or more high-risk factorsAnthony V D'Amico, Ming-Hui Chen, William J Catalona, et al.
Urologic Oncology|January 9, 2010
Biopsy accuracy in identifying unilateral prostate cancer depends on prostate weightMatvey Tsivian, Daniel M Moreira, Leon Sun, et al.
Urologia Internationalis|September 12, 2012
Preoperative predictors of pathologic stage T2a in low-risk prostate cancer: implications for focal therapyQiang Fu, Judd W Moul, Lionel L Bañez, et al.
Pageof 10

Showing results (31-40 of 96) with videos related to

Sort By:
Pageof 10
International Journal of Radiation Oncology, Biology, Physics|January 18, 2011
Impact of primary Gleason grade on risk stratification for Gleason score 7 prostate cancersBridget F Koontz, Matvey Tsivian, Vladimir Mouraviev, et al.
Cancer|July 1, 2010
Baseline PSA as a predictor of prostate cancer-specific mortality over the past 2 decades: Duke University experiencePing Tang, Leon Sun, Matthew A Uhlman, et al.
BJU International|November 6, 2010
Prostate-specific antigen velocity based risk-adapted discontinuation of prostate cancer screening in elderly menPing Tang, Leon Sun, Matthew A Uhlman, et al.
The Prostate|June 11, 2008
Pathologic stage T2a and T2b prostate cancer in the recent prostate-specific antigen era: implications for unilateral ablative therapyThomas J Polascik, Janice M Mayes, Leon Sun, et al.
Medical Oncology (Northwood, London, England)|December 25, 2012
Preoperative predictors of pathologic stage T2a and pathologic Gleason score ≤ 6 in men with clinical low-risk prostate cancer treated with radical prostatectomy: reference for active surveillanceQiang Fu, Judd W Moul, Lionel Bañez, et al.
Urologic Oncology|December 12, 2002
The role of radical prostatectomy in patients with pretreatment prostate-specific antigen > or = 40 ng/mLBill P Vanasupa, Edmond L Paquette, Hongyu Wu, et al.
Urology|November 14, 2002
Improved prostate cancer-specific survival and other disease parameters: impact of prostate-specific antigen testingEdmond L Paquette, Leon Sun, Laurence R Paquette, et al.
Cancer|May 29, 2007
Prostate cancer-specific mortality after radical prostatectomy or external beam radiation therapy in men with 1 or more high-risk factorsAnthony V D'Amico, Ming-Hui Chen, William J Catalona, et al.
Urologic Oncology|January 9, 2010
Biopsy accuracy in identifying unilateral prostate cancer depends on prostate weightMatvey Tsivian, Daniel M Moreira, Leon Sun, et al.
Urologia Internationalis|September 12, 2012
Preoperative predictors of pathologic stage T2a in low-risk prostate cancer: implications for focal therapyQiang Fu, Judd W Moul, Lionel L Bañez, et al.
Pageof 10